Title:
INFLUENZA VIRUS REPLICATION INHIBITOR AND USE THEREOF
Document Type and Number:
WIPO Patent Application WO/2020/177715
Kind Code:
A1
Abstract:
The present invention belongs to the field of medicine, and relates to an influenza virus replication inhibitor and a use thereof, and provided thereby are a novel compound as an influenza virus replication inhibitor and a preparation method therefor, a pharmaceutical composition comprising the compound and an application of the compound and the pharmaceutical composition thereof in treating influenza. The compound according to the present invention is the compound shown in formula (I) or a stereoisomer, a tautomer, an N-oxide, a solvate, a metabolite, a pharmaceutically acceptable salt or a prodrug thereof.
Inventors:
REN QINGYUN (CN)
LUO HUICHAO (CN)
YIN JUNJUN (CN)
WU CHUNLIN (CN)
FAN YUXIN (CN)
MO YUFENG (CN)
ZHANG YINGJUN (CN)
LUO HUICHAO (CN)
YIN JUNJUN (CN)
WU CHUNLIN (CN)
FAN YUXIN (CN)
MO YUFENG (CN)
ZHANG YINGJUN (CN)
Application Number:
PCT/CN2020/077781
Publication Date:
September 10, 2020
Filing Date:
March 04, 2020
Export Citation:
Assignee:
SUNSHINE LAKE PHARMA CO LTD (CN)
International Classes:
C07D471/14; A61K31/53; A61P31/12; A61P31/16; C07D498/14
Domestic Patent References:
| WO2019052565A1 | 2019-03-21 |
Foreign References:
| CN108697715A | 2018-10-23 | |||
| CN103228653A | 2013-07-31 |
Download PDF: